LungFit GO Safe, Well-tolerated, Interim Trial Analysis Shows

LungFit GO Safe, Well-tolerated, Interim Trial Analysis Shows

310101

LungFit GO Safe, Well-tolerated, Interim Trial Analysis Shows

Treatment with LungFit GO, an inhaled form of nitric oxide that can be self-administered at home, has so far been well-tolerated in a pilot clinical trial testing the investigational medication in adults with or without cystic fibrosis (CF). The ongoing trial involves patients with lung infections caused by non-tuberculous mycobacteria, known as NTM, which are environmental organisms found in soil, dust, and water. While these disease-causing bacteria usually aren’t transmitted person-to-person, such transmission has been…

You must be logged in to read/download the full post.